Abbas Sezer

Abbas Sezer serves as an Assistant Professor at the International University of Sarajevo (IUS), focusing on interdisciplinary research bridging oncology, pharmacology, and immunology. His academic profile emphasizes translational studies in cancer therapeutics and viral pathogenesis, with institutional affiliation to Bosnia and Herzegovina's leading private university.

His primary research domains include:

• Oncology: Specializing in lymphoma biology and tumorigenesis mechanisms
• Pharmacology: Investigating natural compounds (polyphenols, thymoquinone) and drug repurposing
• Immunovirology: Exploring microbiome-autoimmunity interactions in Long COVID-19
• Computational Biology: Applying in silico methods to drug discovery

Recent publications (2022-2024) reveal a concentrated effort on lymphoma therapeutics, including xanthene compounds and MALT1 inhibition, alongside significant contributions to understanding Long COVID-19 pathophysiology and vaccine-related myocarditis. His work consistently integrates wet-lab experimentation with computational modeling.

No scientific awards or honors were documented in the source materials.

Dr. Sezer's methodology spans cell culture systems, molecular docking, and clinical evidence reviews, demonstrating particular expertise in translating phytochemical research into potential cancer treatments. His collaborative network appears focused on Balkan and European research initiatives given IUS's regional prominence.